Filing Flows › Fresenius Medical Care AG (FMS) › R&D spending
Fresenius Medical Care AG (FMS) R&D spending by quarter
Fresenius Medical Care AG's R&D spending was $41.4M in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 5 quarters it ranged from $37.7M (Q3 2025) to $41.4M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $41.4M | +4% | +10% |
| Q2 2026 | $39.6M | +4% | +4% |
| Q1 2026 | $38.0M | +0.7% | — |
| Q3 2025 | $37.7M | -1% | — |
| Q2 2025 | $38.1M | — | — |
Q3 2026 at a glance
Fresenius Medical Care AG, Q3 2026: revenue $4.9B (+1% year over year), operating margin 7.8%, net earnings $160M, operating cash flow $798M. The chart follows the revenue to costs, profit and cash.
Questions
What is Fresenius Medical Care AG's R&D spending?
Fresenius Medical Care AG's R&D spending was $41.4M in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has Fresenius Medical Care AG's R&D spending changed?
Over the last 5 quarters it ranged from $37.7M (Q3 2025) to $41.4M (Q3 2026).
Q3 2026 results → · How Fresenius Medical Care AG makes money →